Belongs to a unique family or proteins highly conserved in Kinetoplastida, but not seen outside that group.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0016020 | membrane | 2 | 9 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: E9AD42
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.322 |
CLV_NRD_NRD_1 | 138 | 140 | PF00675 | 0.344 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.355 |
CLV_NRD_NRD_1 | 61 | 63 | PF00675 | 0.627 |
CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.344 |
CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.417 |
DEG_APCC_DBOX_1 | 98 | 106 | PF00400 | 0.440 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.605 |
DOC_MAPK_MEF2A_6 | 145 | 154 | PF00069 | 0.594 |
DOC_PP4_FxxP_1 | 64 | 67 | PF00568 | 0.431 |
DOC_WW_Pin1_4 | 90 | 95 | PF00397 | 0.362 |
LIG_14-3-3_CanoR_1 | 18 | 28 | PF00244 | 0.541 |
LIG_deltaCOP1_diTrp_1 | 11 | 20 | PF00928 | 0.540 |
LIG_eIF4E_1 | 97 | 103 | PF01652 | 0.353 |
LIG_FHA_1 | 105 | 111 | PF00498 | 0.378 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.535 |
LIG_GBD_Chelix_1 | 150 | 158 | PF00786 | 0.428 |
LIG_LIR_Gen_1 | 147 | 156 | PF02991 | 0.631 |
LIG_LIR_Nem_3 | 107 | 111 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 147 | 152 | PF02991 | 0.599 |
LIG_PCNA_yPIPBox_3 | 138 | 150 | PF02747 | 0.650 |
LIG_PDZ_Class_2 | 162 | 167 | PF00595 | 0.688 |
LIG_SH2_CRK | 97 | 101 | PF00017 | 0.313 |
LIG_SH2_STAT3 | 126 | 129 | PF00017 | 0.542 |
LIG_SH2_STAT3 | 92 | 95 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 126 | 129 | PF00017 | 0.542 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.625 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.354 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 92 | 95 | PF00017 | 0.357 |
LIG_SH3_3 | 100 | 106 | PF00018 | 0.407 |
LIG_WRC_WIRS_1 | 105 | 110 | PF05994 | 0.411 |
MOD_N-GLC_1 | 160 | 165 | PF02516 | 0.464 |
MOD_NEK2_2 | 56 | 61 | PF00069 | 0.365 |
MOD_PIKK_1 | 160 | 166 | PF00454 | 0.645 |
MOD_Plk_1 | 160 | 166 | PF00069 | 0.666 |
MOD_Plk_1 | 3 | 9 | PF00069 | 0.577 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.319 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.550 |
MOD_ProDKin_1 | 90 | 96 | PF00069 | 0.363 |
MOD_SUMO_for_1 | 1 | 4 | PF00179 | 0.605 |
MOD_SUMO_rev_2 | 147 | 157 | PF00179 | 0.704 |
MOD_SUMO_rev_2 | 71 | 78 | PF00179 | 0.488 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.624 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.295 |
TRG_ER_diArg_1 | 120 | 122 | PF00400 | 0.536 |
TRG_ER_diArg_1 | 138 | 140 | PF00400 | 0.546 |
TRG_ER_diArg_1 | 60 | 62 | PF00400 | 0.407 |
TRG_Pf-PMV_PEXEL_1 | 138 | 142 | PF00026 | 0.433 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P780 | Leptomonas seymouri | 82% | 100% |
A0A0S4JRI7 | Bodo saltans | 62% | 99% |
A0A1X0P491 | Trypanosomatidae | 63% | 99% |
A0A3Q8IE57 | Leishmania donovani | 98% | 100% |
A0A422NMQ9 | Trypanosoma rangeli | 66% | 99% |
A4HFJ1 | Leishmania braziliensis | 92% | 100% |
D0A5R7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 99% |
E9AHD5 | Leishmania infantum | 98% | 100% |
E9AYW6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |